Genomic analysis and in vivo efficacy of pediococcus acidilactici as a potential probiotic to prevent hyperglycemia, hypercholesterolemia and gastrointestinal infections

HIGHLIGHTS

• who: Hassan M. Al-Emran from the DepartmentJashore University have published the Article: Genomic analysis and in vivo efficacy of Pediococcus acidilactici as a potential probiotic to prevent hyperglycemia, hypercholesterolemia and gastrointestinal infections, in the Journal: Scientific Reports Scientific Reports
• what: In the next phase of this study, the authors conducted a very successful in_vivo trail for all 4 strains with 3 control groups and found that that the average blood glucose levels dropped significantly in 3 probiotic groups (p and amp;lt; 0.0001 in C6, p and amp;lt; 0.013 in G11 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.